Enterococcus and Staphylococcus aureus/epidermidis vaccine conjugate - Nabi
Alternative Names: CombiVaxLatest Information Update: 23 May 2006
At a glance
- Originator Nabi Biopharmaceuticals
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Enterococcal infections; Staphylococcal infections
Most Recent Events
- 23 May 2006 Discontinued - Preclinical for Enterococcal infections in USA (unspecified route)
- 23 May 2006 Discontinued - Preclinical for Staphylococcal infections in USA (unspecified route)
- 12 Aug 2004 No development reported - Preclinical for Enterococcal infections in USA (unspecified route)